DSpace

DSpace at RU >    University Library >    Academic bibliography >

SFX Query

Files in This Item:

File Description SizeFormat
publisher's version254.22 kBAdobe PDFUnder Embargo

Title: Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology.
Author(s): Dumont, G.J.H. (298981076)
Kramers, C. (142708208)
Sweep, F.C. (074620967)
Willemsen, J.J. (298203499)
Touw, D.J.
Schoemaker, R.C.
Gerven, J.M. van
Buitelaar, J.K. (081545622)
Verkes, R.J. (165890444)
Publication year: 2010
Document type: Article / Letter to editor
Journal: Journal of Psychopharmacology
ISSN: 0269-8811
Volume: vol. 24
Issue: iss. 2
Start page: p. 165
End page: p. 174
Abstract: Alcohol is frequently used in combination with 3,4-methylenedioxymethamphetamine (MDMA). Both drugs affect cardiovascular function, hydration and temperature regulation, but may have partly opposing effects. The present study aims to assess the acute physiologic effects of (co-) administration of MDMA and ethanol over time. A four-way, double blind, randomized, crossover, placebo-controlled study in 16 healthy volunteers (9 male and 7 female) between the ages of 18 and 29. MDMA (100 mg) was given orally and blood ethanol concentration was maintained at pseudo-steady state levels of 0.6 per thousand by a three-hour 10% intravenous ethanol clamp. Cardiovascular function, temperature and hydration measures were recorded throughout the study days. Ethanol did not significantly affect physiologic function, with the exception of a short lasting increase in heart rate. MDMA potently increased heart rate and blood pressure and induced fluid retention as well as an increase in temperature. Co-administration of ethanol with MDMA did not affect cardiovascular function compared to the MDMA alone condition, but attenuated the effects of MDMA on fluid retention and showed a trend for attenuation of MDMA-induced temperature increase. In conclusion, co-administration of ethanol and MDMA did not exacerbate physiologic effects compared to all other drug conditions, and moderated some effects of MDMA alone.
Subject: DCN 1: Perception and Action
DCN 2: Functional Neurogenomics
IGMD 6: Hormonal regulation
NCEBP 14: Cardiovascular diseases
NCEBP 6: Quality of nursing and allied health care
NCEBP 9: Mental Health
Subject: NCEBP 9: Mental Health
Organization: Psychiatry
General Internal Medicine
Pharmacology-Toxicology
Laboratory of Genetic, Endocrine and Metabolic Diseases
Chemical Endocrinology
UMCN Extern
Cognitive Neuroscience
Appears in Collections:Academic bibliography

Please use this identifier to cite or link to this item: http://hdl.handle.net/2066/88694

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback